Perrigo to Attend Canaccord Genuity 45th Annual Growth Conference

Perrigo Company is at the forefront of providing Consumer Self-Care Products and over-the-counter (OTC) health and wellness solutions, aiming to improve individual well-being by enabling consumers to address self-manageable conditions effectively.

Perrigo is anticipated to present at the Canaccord Genuity 45th Annual Growth Conference, with notable figures such as President and CEO Patrick Lockwood-Taylor and CFO Eduardo Bezerra scheduled to participate on Tuesday, August 12th at 9:00 AM EDT. Those interested can tune into the webcast on the Perrigo website at the specified time.

Perrigo Company plc stands out as a predominant self-care company, boasting a wealth of experience spanning over a century in delivering top-notch health and wellness solutions to consumers, primarily situated in North America and Europe. Serving as a pioneer in the over-the-counter (OTC) self-care sector, Perrigo offers trusted self-care remedies that do not necessitate a prescription, thereby ensuring accessibility and diverse choices for consumers encompassing various molecules, dosage forms, and value categories.

Perrigo’s distinctive business model draws on its synergistic enterprises, where revenue generated from store brand private label offerings drives investments for leading brands such as Opill®, Mederma®, Compeed®, EllaOne®, and Jungle Formula®. This strategic approach allows Perrigo to offer an array of solutions to cater to the varying needs and preferences of consumers, consolidating its position as a premier provider in the sector.

For more detailed insights into Perrigo’s offerings and operations, you can visit the official Perrigo website.

It is important to note that this press release may contain certain forward-looking statements in compliance with the Private Securities Litigation Reform Act of 1995. Forward-looking statements are subject to inherent risks, uncertainties, and external factors, many of which are beyond Perrigo’s control, that could lead to considerable variances between actual results and anticipated outcomes. Stakeholders are advised to refer to Perrigo’s filings with the United States Securities and Exchange Commission for a comprehensive examination of the company’s financial condition, business operations, and significant trends, risks, uncertainties, and other pertinent factors.

In conclusion, Perrigo Company remains dedicated to delivering exceptional Consumer Self-Care Products and OTC health solutions, focusing on empowering individuals to take charge of their health proactively. Through its longstanding presence and commitment to innovation, Perrigo continues to be a trailblazer in enhancing consumer well-being through accessible and effective self-care solutions.